Literature DB >> 29377109

Trauma induced heterotopic ossification patient serum alters mitogen activated protein kinase signaling in adipose stem cells.

Elizabeth C Martin1, Ammar T Qureshi2, Claire B Llamas3, Elaine C Boos4, Andrew G King4, Peter C Krause4, Olivia C Lee4, Vinod Dasa4, Michael A Freitas5, Jonathan A Forsberg6, Eric A Elster6, Thomas A Davis2,6, J M Gimble3,7,8.   

Abstract

Post-traumatic heterotopic ossification (HO) is the formation of ectopic bone in non-osseous structures following injury. The precise mechanism for bone development following trauma is unknown; however, early onset of HO may involve the production of pro-osteogenic serum factors. Here we evaluated serum from a cohort of civilian and military patients post trauma to determine early induction gene signatures in orthopaedic trauma induced HO. To test this, human adipose derived stromal/stem cells (hASCs) were stimulated with human serum from patients who developed HO following trauma and evaluated for a gene panel with qPCR. Pathway gene analysis ontology revealed that hASCs stimulated with serum from patients who developed HO had altered gene expression in the activator protein 1 (AP1) and AP1 transcriptional targets pathways. Notably, there was a significant repression in FOS gene expression in hASCs treated with serum from individuals with HO. Furthermore, the mitogen-activated protein kinase (MAPK) signaling pathway was activated in hASCs following serum exposure from individuals with HO. Serum from both military and civilian patients with trauma induced HO had elevated downstream genes associated with the MAPK pathways. Stimulation of hASCs with known regulators of osteogenesis (BMP2, IL6, Forskolin, and WNT3A) failed to recapitulate the gene signature observed in hASCs following serum stimulation, suggesting non-canonical mechanisms for gene regulation in trauma induced HO. These findings provide new insight for the development of HO and support ongoing work linking the systemic response to injury with wound specific outcomes.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  AP1; MAPK; adipose stem cells; heterotopic ossification; osteogenesis

Mesh:

Substances:

Year:  2018        PMID: 29377109      PMCID: PMC8083017          DOI: 10.1002/jcp.26504

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  28 in total

1.  Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).

Authors:  Jennifer L Fiori; Paul C Billings; Lourdes Serrano de la Peña; Frederick S Kaplan; Eileen M Shore
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

Review 2.  Heterotopic ossification: a review.

Authors:  E F McCarthy; M Sundaram
Journal:  Skeletal Radiol       Date:  2005-08-25       Impact factor: 2.199

3.  Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program.

Authors:  Natalia Artigas; Carlos Ureña; Edgardo Rodríguez-Carballo; José Luis Rosa; Francesc Ventura
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

Review 4.  Regulation of cell signalling by uPAR.

Authors:  Harvey W Smith; Chris J Marshall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

5.  Inflammatory cytokine and chemokine expression is associated with heterotopic ossification in high-energy penetrating war injuries.

Authors:  Korboi N Evans; Jonathan A Forsberg; Benjamin K Potter; Jason S Hawksworth; Trevor S Brown; Romney Andersen; James R Dunne; Douglas Tadaki; Eric A Elster
Journal:  J Orthop Trauma       Date:  2012-11       Impact factor: 2.512

Review 6.  TGF-β and BMP signaling in osteoblast differentiation and bone formation.

Authors:  Guiqian Chen; Chuxia Deng; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2012-01-21       Impact factor: 6.580

7.  Lower limb orthopaedic surgery results in changes to coagulation and non-specific inflammatory biomarkers, including selective clinical outcome measures.

Authors:  Stephen F Hughes; Beverly D Hendricks; David R Edwards; Salah S Bastawrous; Jim F Middleton
Journal:  Eur J Med Res       Date:  2013-11-09       Impact factor: 2.175

8.  Characterization of Cells Isolated from Genetic and Trauma-Induced Heterotopic Ossification.

Authors:  Shailesh Agarwal; James Drake; Ammar T Qureshi; Shawn Loder; Shuli Li; Kay Shigemori; Jonathan Peterson; David Cholok; Jonathan A Forsberg; Yuji Mishina; Thomas A Davis; Benjamin Levi
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

9.  P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.

Authors:  Yingze Zhao; Tao Song; Wenjuan Wang; Jin Wang; Juanwen He; Ningning Wu; Min Tang; Baicheng He; Jinyong Luo
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

10.  uPA deficiency exacerbates muscular dystrophy in MDX mice.

Authors:  Mònica Suelves; Berta Vidal; Antonio L Serrano; Marc Tjwa; Josep Roma; Roser López-Alemany; Aernout Luttun; María Martínez de Lagrán; Angels Díaz-Ramos; Maria Angels Díaz; Mercè Jardí; Manuel Roig; Mara Dierssen; Mieke Dewerchin; Peter Carmeliet; Pura Muñoz-Cánoves
Journal:  J Cell Biol       Date:  2007-09-04       Impact factor: 10.539

View more
  4 in total

1.  Comparative proteomic analysis identifies differentially expressed proteins and reveals potential mechanisms of traumatic heterotopic ossification progression.

Authors:  Zhenyuan Wei; Shang Guo; Hongwei Wang; Yang Zhao; Jiren Yan; Chi Zhang; Biao Zhong
Journal:  J Orthop Translat       Date:  2022-05-14       Impact factor: 4.889

2.  Demethylation of ITGAV accelerates osteogenic differentiation in a blast-induced heterotopic ossification in vitro cell culture model.

Authors:  Niall J Logan; Marie Camman; Greg Williams; Claire A Higgins
Journal:  Bone       Date:  2018-09-13       Impact factor: 4.398

Review 3.  Changes of Migration, Immunoregulation and Osteogenic Differentiation of Mesenchymal Stem Cells in Different Stages of Inflammation.

Authors:  Feng Gu; Ke Zhang; Jiangbi Li; Xiaoping Xie; Qiangqiang Wen; Zhenjiang Sui; Zilong Su; Tiecheng Yu
Journal:  Int J Med Sci       Date:  2022-01-01       Impact factor: 3.738

4.  Silencing of SPARC represses heterotopic ossification via inhibition of the MAPK signaling pathway.

Authors:  Qianjun Wang; Qianqian Yang; Ali Zhang; Zhiqiang Kang; Yingsheng Wang; Zhentao Zhang
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.